Literature DB >> 30777207

MRI texture analysis based on 3D tumor measurement reflects the IDH1 mutations in gliomas - A preliminary study.

Liang Han1, Siyu Wang2, Yanwei Miao3, Huicong Shen4, Yan Guo5, Lizhi Xie6, Yuqing Shang7, Junyi Dong8, Xiaoxin Li8, Weiwei Wang8, Qingwei Song8.   

Abstract

OBJECTIVE: To evaluate the differentiation efficiency of texture analysis of T1WI, T2WI and contrasted-enhanced T1WI MRI sequences in gliomas with and without IDH1 mutation based on entire tumor region.
MATERIALS AND METHODS: A total of 42 patients with histopathologically confirmed gliomas, including 21 patients carrying IDH1 mutation (IDH1mutation group) and 21 with wild-type IDH1 (IDH1wt group) were included in this study. The preoperative MRI and clinical data were collected. The regions of interest (ROIs) covering the entire tumor and edema were manually delineated on axial slices using O.K. (Omni Kinetics, GE Healthcare, China) software; and the histogram and GLCM features based on T1WI, T2WI and contrasted-enhanced T1WI sequences were automatically generated.
RESULTS: Based on contrasted-enhanced T1WI features, the inertia resulted as the best feature for diagnosis, with the AUC of 0.844. Furthermore, the AUC for gliomas prediction with IDH1mutation was 0.800 for cluster prominence. IDH1-mutation was differentiated on T2WI with the highest AUC of 0.848, which corresponded to GLCM Entropy. After modeling, the accuracy of the contrasted-enhanced T1WI, T1WI, and T2WI features model was 0.952, 0.857, and 0.738, respectively. The AUC of Joint VariableT1WI+C for predicting IDH1mutation was 0.984, while the AUC of Joint VariableT1WI for predicting the same mutation was 0.927. The diagnostic efficiency of Joint VariableT2WI was also desirable.
CONCLUSION: MRI texture analysis could be used as a new noninvasive method for identification of gliomas with IDH1 mutation. The present results show that the Joint Variable derived from conventional MR imaging histogram and GLCM features is suitable for precise detection of IDH1-mutated gliomas.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gliomas; Isocitrate dehydrogenase 1; Magnetic resonance imaging

Mesh:

Substances:

Year:  2019        PMID: 30777207     DOI: 10.1016/j.ejrad.2019.01.025

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  7 in total

1.  Predicting MGMT Promoter Methylation in Diffuse Gliomas Using Deep Learning with Radiomics.

Authors:  Sixuan Chen; Yue Xu; Meiping Ye; Yang Li; Yu Sun; Jiawei Liang; Jiaming Lu; Zhengge Wang; Zhengyang Zhu; Xin Zhang; Bing Zhang
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

2.  Machine learning-based quantitative texture analysis of conventional MRI combined with ADC maps for assessment of IDH1 mutation in high-grade gliomas.

Authors:  Deniz Alis; Omer Bagcilar; Yeseren Deniz Senli; Mert Yergin; Cihan Isler; Naci Kocer; Civan Islak; Osman Kizilkilic
Journal:  Jpn J Radiol       Date:  2019-11-18       Impact factor: 2.374

3.  Noninvasive Prediction of TERT Promoter Mutations in High-Grade Glioma by Radiomics Analysis Based on Multiparameter MRI.

Authors:  Hongan Tian; Hui Wu; Guangyao Wu; Guobin Xu
Journal:  Biomed Res Int       Date:  2020-05-15       Impact factor: 3.411

4.  A Bayesian 2D functional linear model for gray-level co-occurrence matrices in texture analysis of lower grade gliomas.

Authors:  Thierry Chekouo; Shariq Mohammed; Arvind Rao
Journal:  Neuroimage Clin       Date:  2020-09-18       Impact factor: 4.881

5.  Differentiating Between Multiple Myeloma and Metastasis Subtypes of Lumbar Vertebra Lesions Using Machine Learning-Based Radiomics.

Authors:  Xing Xiong; Jia Wang; Su Hu; Yao Dai; Yu Zhang; Chunhong Hu
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

6.  Radiomics-Based Machine Learning Technology Enables Better Differentiation Between Glioblastoma and Anaplastic Oligodendroglioma.

Authors:  Yimeng Fan; Chaoyue Chen; Fumin Zhao; Zerong Tian; Jian Wang; Xuelei Ma; Jianguo Xu
Journal:  Front Oncol       Date:  2019-11-05       Impact factor: 6.244

Review 7.  Radiomics and radiogenomics in gliomas: a contemporary update.

Authors:  Prateek Prasanna; Vadim Spektor; Gagandeep Singh; Sunil Manjila; Nicole Sakla; Alan True; Amr H Wardeh; Niha Beig; Anatoliy Vaysberg; John Matthews
Journal:  Br J Cancer       Date:  2021-05-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.